OncoTargets and Therapy (Feb 2017)
Significance of downregulation of renal organic cation transporter (SLC47A1) in cisplatin-induced proximal tubular injury [Corrigendum]
Abstract
Mizuno T, Sato W, Ishikawa K, et al. Onco Targets Ther. 2015;8:1701–1706. On page 1703, Figure 1, the y-axis label for parts A and B should have read “Fold change (MATE/SLC47A1 mRNA/GAPDH mRNA)” rather than “Fold change (TG2 mRNA/GAPDH mRNA)”. “TG2, transglutaminase 2” also should be removed from the abbreviations list. Read the original article